Monday - August 3, 2026
Goodwin Advises Oak Hill Bio on $175 Million Business Combination Agreement With Research Alliance Corporation III to Create Publicly Listed Rare Disease Biotechnology Company
July 28, 2026
BOSTON, Massachusetts, July 28 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Oak Hill Bio on $175 Million Business Combination Agreement With Research Alliance Corporation III to Create Publicly Listed Rare Disease Biotechnology Company

*

The Life Sciences team advised OHB Pediatrics Ltd. d/b/a Oak Hill Bio on entering into a definitive business combination agreement with RACC, a speci . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products